75 related articles for article (PubMed ID: 9515717)
1. A novel flow cytometric method for the quantification of p53 gene expression.
Filippini G; Griffin S; Uhr M; Eppenberger H; Bonilla J; Cavalli F; Soldati G
Cytometry; 1998 Mar; 31(3):180-6. PubMed ID: 9515717
[TBL] [Abstract][Full Text] [Related]
2. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry.
Bonsing BA; Corver WE; Gorsira MC; van Vliet M; Oud PS; Cornelisse CJ; Fleuren GJ
Cytometry; 1997 May; 28(1):11-24. PubMed ID: 9136751
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
Saied IT; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
[TBL] [Abstract][Full Text] [Related]
4. Quantification of p53 protein in tumor cell lines, breast tissue extracts and serum with time-resolved immunofluorometry.
Hassapoglidou S; Diamandis EP; Sutherland DJ
Oncogene; 1993 Jun; 8(6):1501-9. PubMed ID: 8502476
[TBL] [Abstract][Full Text] [Related]
5. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
[TBL] [Abstract][Full Text] [Related]
6. [Expression of tumor suppressor genes p16, p21 and p53 in a pair of lung adenocarcinoma cell lines with different metastasis potentials: Anip973 and AGZY83-a].
Wang B; Yan C; Wu Y; Gao H; Wang Q; Jin Y; Huang C; Zhang G; Fu S; Li P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):128-31. PubMed ID: 11295133
[TBL] [Abstract][Full Text] [Related]
7. Intracellular detection of Bcl-2 and p53 proteins by flow cytometry: comparison of monoclonal antibodies and sample preparation protocols.
Zamai L; Canonico B; Gritzapis A; Luchetti F; Felici C; Della Felice M; Margomenou L; Papamichail M; Gratama JW; Papa S
J Biol Regul Homeost Agents; 2002; 16(4):289-302. PubMed ID: 12597645
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometry of p53 protein expression in some hematological malignancies.
Koníková E; Kusenda J; Babusíková O
Neoplasma; 1999; 46(6):368-76. PubMed ID: 10732866
[TBL] [Abstract][Full Text] [Related]
10. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
[TBL] [Abstract][Full Text] [Related]
11. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
12. P53 protein expression in human leukemia and lymphoma cells.
Koníková E; Kusenda J
Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
[TBL] [Abstract][Full Text] [Related]
13. Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.
Buttgereit P; Schakowski F; Märten A; Brand K; Renoth S; Ziske C; Schöttker B; Ebert O; Schroers R; Schmidt-Wolf IG
Cancer Gene Ther; 2001 Jun; 8(6):430-9. PubMed ID: 11498763
[TBL] [Abstract][Full Text] [Related]
14. p53 dependence and apoptosis in response to FP treatment with p53-transfected colon cancer cell lines by use of thin layer collagen gel.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2004 Aug; 12(2):357-61. PubMed ID: 15254702
[TBL] [Abstract][Full Text] [Related]
15. [Effect of exogenous p16 gene on the growth of wild-type p53 human lung adenocarcinoma cells].
Fu X; Zhang S; Ran R
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):102-4. PubMed ID: 11776846
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric quantification of cyclin E in human cell lines and hematopoietic malignancies.
Erlanson M; Landberg G
Cytometry; 1998 Jul; 32(3):214-22. PubMed ID: 9667511
[TBL] [Abstract][Full Text] [Related]
17. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
18. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
Fan S; Cherney B; Reinhold W; Rucker K; O'Connor PM
Clin Cancer Res; 1998 Apr; 4(4):1047-54. PubMed ID: 9563901
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
[TBL] [Abstract][Full Text] [Related]
20. Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell lines.
Danks MK; Whipple DO; McPake CR; Lu D; Harris LC
Cell Death Differ; 1998 Aug; 5(8):678-86. PubMed ID: 10200523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]